EuResist Database
EuResist DB

CHAIN

The CHAIN project (Collaborative HIV and Anti-HIV Drug Resistance Network) aims at effectively and durably combat new and existing anti-HIV drug resistance in clinical settings, with a special emphasis on Eastern Europe and in heavily affected resource-poor regions in Africa. 

This will be achieved through a pan-European network of surveillance and basic research activities, the involvement of all main actors in the field of HIV and anti-HIV drug resistance, monitoring how resistances develop and evolve, improved understanding of mechanisms of resistance development, performing molecular epidemiology studies, providing improved and new strategies to evaluate and limit the emergence and transmission of HIV drug resistance, setting up training and dissemination activities and supporting evidence-based public health policy and action.

EuResist Network is responsible for main deliverables in Work Package 4 ” MOLECULAR EPIDEMIOLOGY AND BIOINFORMATICS CLUSTER”.

 

Funded by the European Union

  • Start date: 01/02/09
  • End date: 31/03/14
  • EC grant: FP7 HEALTH
  • Grant agreement: 223131
  • Total grant: 9.988.092 €

Participants

  1. University College London (UK)
  2. Erasmus Universitair Medisch Centrum Rotterdam (Nl)
  3. Informa Srl (IT)
  4. Association De Recherche En Virologie et Dermatologie (FR)
  5. Fundacio Privada Institut de Recerca de la Sida-Caixa (ES)
  6. Medical Research Council (UK)
  7. Fondazione Penta-for the Treatment and Care of Children with HIV-Onlus (IT)
  8. Københavns Universitet (DK)
  9. Université de Bordeaux (FR)
  10. Fondazione Icona (IT)
  11. Universite Cheikh Anta Diop de Dakar (SN)
  12. D.I. Ivanovsky Institute of Virology of The Ministry of Health And Social Development of the Russian Federation (RU)
  13. Univerza v Ljubljani (SI)
  14. World Health Organization (CH)
  15. Karolinska Institutet (SE)
  16. Universitaet Zuerich (CH)
  17. Katholieke Universiteit Leuven (BE)
  18. Robert Koch-Institut (DE)
  19. Instituto de Higiene e Medicina Tropical (PT) Servicio Madrileno de Salud (ES)
  20. Janssen Pharmaceutica N V (BE)
  21. Euresist Network GEIE (IT)
  22. Università degli Studi di Roma Tor Vergata (IT)

This project has received funding from the European Union’s Framework Programme For Research 7 (FP7) under grant agreement No 223131 

 Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.